Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology Mar 15, 2022
Read: BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development Mar 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies Feb 14, 2022
Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology Feb 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates Dec 13, 2021
Read: BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany Nov 2, 2021
Read: AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design Oct 19, 2021
Read: AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders Oct 13, 2021
Read: BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen Aug 2, 2021
Read: BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology Jul 5, 2021
Read: BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity May 17, 2021
Read: BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim Mar 29, 2021
Read: BioMed X Institute starts new research project in drug delivery in collaboration with Janssen BioMed X Institute starts new research project in drug delivery in collaboration with Janssen Jan 26, 2021
Read: BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim Dec 8, 2020
Read: BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research Nov 9, 2020
Read: BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics May 13, 2020
Read: BioMed X starts new schizophrenia research program with Boehringer Ingelheim BioMed X starts new schizophrenia research program with Boehringer Ingelheim Jan 13, 2020
Read: BioMed X starts new research program in autoimmune diseases with Merck BioMed X starts new research program in autoimmune diseases with Merck Jan 9, 2020
Read: BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases Jan 17, 2019
Read: BioMed X and Merck extend research collaboration in oncology BioMed X and Merck extend research collaboration in oncology May 8, 2018
Read: BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity Nov 27, 2017
In the Media In the Media Media is constantly reporting on BioMed X and its work. Read our current media coverage. Read more
Past Lunch Talks Past Lunch Talks In the “Lunch Talk Series“, group leaders from BioMed X and the Postdoc Network of the German Cancer Research Center (DKFZ) invite renowned life scientists to share their research and foster scientific exchanges. Read more
